Value-based care is frequently viewed from a population health perspective. Our panel discussed how value-based care in oncology must evolve to better address the needs of patients and how outcomes can be optimized through communication and collaboration.
Key highlights
- Standard approaches and metrics assessing value-based care have not always considered the impact to the patient
- Patients should be engaged in shared decision-making; the care team should have transparent discussions with them about the value of the care they are receiving
- Clinical trials in oncology need to evolve to include endpoints such as patient-reported outcomes
- Optimizing ways of communicating with patients is essential to achieving value-based care and helping support them throughout their treatment journey
- Investment in ancillary services and support—patient navigators, clinical pharmacists, social workers—increases value irrespective of payment models